Skip to main content

NucleoTech

nucleo-tech.com

This company develops nanotechnology-based drug delivery systems to transport therapeutics across the blood-brain barrier. Their technology enables the delivery of biologics and RNA drugs directly into the brain, improving treatment options for central nervous system disorders.

Traction –/10
רחובות, Israel · HQ
7200+ followers
  • Biotechnology
Updated 5 months ago

Funding

Funding rounds are not available yet.

Founders

2 founders

Uriah Bekenstein

CEO

Adi Koplovitz

Co-Founder

Product

Features

  • This company develops nanotechnology-based drug delivery systems to transport therapeutics across the blood-brain barrier. Their technology enables the delivery of biologics and RNA drugs directly into the brain, improving treatment options for central nervous system disorders.
1
This profile is AI-generated and may contain inaccuracies.